gsk glp-1 promotes osteogenic differentiation of human ADSCs via the Wnt/GSK-3β/β-catenin pathway GSK-3 inhibition through GLP-1R allosteric

Both medications have shown potential in supporting cardiovascular health

Overdosage Overdoses have been reported in clinical trials and post-marketing use of liraglutide

doi:10.1097/LVT.0000000000000233 20

These programs are funded through payroll contributions, typically deducted from employee wages, sometimes matched by employers

Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials

The plausible timeline, reconstructed from Lilly's disclosed trial schedule and standard regulatory review windows, looks roughly like this: Q2-Q3 2026: TRIUMPH-1 and TRIUMPH-2 readouts